People · Operator
Named in public records as an officer, director or promoter · active 2011–2017 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Morris Innovative Inc. | — | Other Health Care | Seed | $4.7M | $86.7M | 2017 |
| Immunologix, Inc. | — | Biotechnology | Seed | $1.5M | $11.1M | 2011 |
Mark Bartosh at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Bartosh on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Lloyd A. Pearson | 1 | 3 |
| Douglas M. Carnes | 1 | 3 |
| Ryan N. Fiorini | 1 | 3 |
| Sam A Tetlow | 1 | 2 |
| Ray Tichenor | 1 | 1 |
| Gabriel Browne | 1 | 1 |
| Andrew Denardo | 1 | 1 |
| Richard Zimmer III | 1 | 1 |
| Richard A. McGregor | 1 | 1 |
| Robert N. Kennedy | 1 | 1 |
| Robert A. Kennedy | 1 | 1 |
| Ron Steckel | 1 | 1 |
| Mark A. Bartosh | 1 | 1 |
| Edward Morris | 1 | 1 |
| Amy Manoukian | 1 | 1 |
| Robert McCormack | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.